Improved glycaemic control with carbohydrate counting for adjustment of fast-acting insulin aspart versus insulin aspart in subjects with type 1 diabetes

被引：0
|
作者：
Philis-Tsimikas, A. [1 ]
Bode, B. W. [2 ]
Franek, E. [3 ]
Rose, L. [4 ]
Buchholtz, K. [5 ]
Demissie, M. [5 ]
Pieber, T. R. [6 ]
机构：
[1] Scripps Whittier Diabet Inst, San Diego, CA USA
[2] Atlanta Diabet Associates, Atlanta, GA USA
[3] Mossakowski Clin Res Ctr, Warsaw, Poland
[4] Inst Diabet Res, Munster, Germany
[5] Novo Nordisk AS, Soborg, Denmark
[6] Med Univ Graz, Div Endocrinol & Diabetol, Graz, Austria
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
689
引用
收藏
页码：S315 / S315
页数：1
相关论文
共 50 条
  • [1] Improved glycaemic control with carbohydrate counting for adjustment of fast-acting insulin aspart versus insulin aspart in subjects with type 1 diabetes
    Twigg, Stephen
    Philis-Tsimikas, Athena
    Bode, Bruce
    Franek, Edward
    Rose, Ludger
    Buchholtz, Kristine
    Demissie, Marek
    Pieber, Thomas R.
    [J]. CLINICAL ENDOCRINOLOGY, 2018, 89 : 64 - 64
  • [2] Improved glycaemic control with carbohydrate counting for adjustment of fast-acting insulin aspart vs insulin aspart in subjects with Type 1 diabetes
    Leelarathna, L.
    Philis-Tsimikas, A.
    Bode, B. W.
    Franek, E.
    Rose, L.
    Buchholtz, K.
    Pieber, T. R.
    [J]. DIABETIC MEDICINE, 2018, 35 : 19 - 19
  • [3] Improved Glycemic Control with Carbohydrate Counting for Adjustment of Fast-Acting Insulin Aspart vs. Insulin Aspart in Subjects with Type 1 Diabetes
    Philis-Tsimikas, Athena
    Bode, Bruce W.
    Franek, Edward
    Rose, Ludger
    Buchholtz, Kristine
    Demissie, Marek
    Pieber, Thomas R.
    [J]. DIABETES, 2017, 66 : A260 - A260
  • [4] Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
    Haahr, Hanne
    Pieber, Thomas R.
    Mathieu, Chantal
    Gondolf, Theis
    Shiramoto, Masanari
    Erichsen, Lars
    Heise, Tim
    [J]. CLINICAL PHARMACOKINETICS, 2019, 58 (05) : 639 - 649
  • [5] Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
    Hanne Haahr
    Thomas R. Pieber
    Chantal Mathieu
    Theis Gondolf
    Masanari Shiramoto
    Lars Erichsen
    Tim Heise
    [J]. Clinical Pharmacokinetics, 2019, 58 : 639 - 649
  • [6] Hypoglycaemia with mealtime fast-acting insulin aspart versus insulin aspart across two large type 1 diabetes trials
    De Block, C.
    Carlson, A.
    Rose, L.
    Gondolf, T.
    Gorst-Rasmussen, A.
    Boesgaard, T. W.
    Lane, W.
    [J]. DIABETOLOGIA, 2018, 61 : S31 - S32
  • [7] Efficacy and safety of fast-acting insulin aspart versus insulin aspart in children and adolescents with type 1 diabetes from Japan
    Kawamura, Tomoyuki
    Kikuchi, Toru
    Horio, Hiroshi
    Rathor, Naveen
    Ekelund, Magnus
    [J]. ENDOCRINE JOURNAL, 2021, 68 (04) : 409 - 420
  • [8] IMPROVED POSTPRANDIAL GLYCAEMIC CONTROL WITH FASTER-ACTING INSULIN ASPART VS INSULIN ASPART IN SUBJECTS WITH TYPE 1 DIABETES USING CSII IN PUMPS
    Bode, B. W.
    Hyveled, L.
    Tamer, S. C.
    Demissie, M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A40 - A40
  • [9] Fast-Acting Insulin aspart (faster aspart) - Clinical Data on Application in Type 1 and 2 Diabetes
    Jaeckel, E.
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (06): : 313 - 319
  • [10] Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes
    Bowering, K.
    Harvey, J.
    Kolaczynski, J. W.
    Snyder, J. W.
    Bode, B. W.
    [J]. DIABETIC MEDICINE, 2019, 36 (06) : 771 - 775
12345